ResearcherJinan UniversityActive in the last 2 years

Hui Deng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9937-1391; OpenAlex author ID A5083023414. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper

Papers 1

Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer. Co-author DOI 10.1016/j.mcp.2023.101948 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shurui Zhou · 1 shared paper, 2024 · strength 0.23
- Paper Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer. DOI 10.1016/j.mcp.2023.101948 ↗
Yuzhou Huang · 1 shared paper, 2024 · strength 0.23
- Paper Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer. DOI 10.1016/j.mcp.2023.101948 ↗
Yunlong Li · 1 shared paper, 2024 · strength 0.23
- Paper Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer. DOI 10.1016/j.mcp.2023.101948 ↗
Jianchang Shu · 1 shared paper, 2024 · strength 0.23
- Paper Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer. DOI 10.1016/j.mcp.2023.101948 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.